Blake B. Greene

blake-greene

Blake B. Greene

Associate

Austin | 300 W. 6th Street, Suite 2010, Austin, TX 78701-2916
+1 512 394 3041 | +1 512 394 3001

| vCard | PDF

Blake Greene represents clients in intellectual property litigation, with a particular emphasis in patent litigation. While his primary focus involves life sciences matters, Mr. Greene’s practice spans a broad array of industries and technologies, including pharmaceuticals, video signal processing, network communication for online gaming products, insurance claim processing, portfolio analysis, DNA sequencing, computer microarchitecture, location determination, semiconductor processing equipment, and consumer electronics. Mr. Greene has handled all phases of litigation, including pre-suit investigation, fact and expert discovery, Markman, motion practice, trial, and appeal, and has served as lead associate in a number of cases.

Mr. Greene has extensive experience in patent litigation under the Hatch-Waxman Act. Recently, he helped secure three trial victories for Endo Pharmaceuticals Inc. against multiple generic companies relating to Endo’s flagship OPANA ER® (extended-release oxymorphone hydrochloride) product.

Prior to joining Dechert, Mr. Greene worked as an associate in the patent litigation practices of three nationally recognized law firms.

Significant Representations

  • Endo Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA, Inc. et al. (D. Del.). Trial counsel for Endo Pharmaceuticals in Hatch-Waxman case filed against two generic companies involving Endo's OPANA ER® product. Following a bench trial, the court ruled in Endo's favor, finding the asserted patent not invalid. Currently on appeal.
  • Endo Pharmaceuticals Inc. et al. v. Actavis Inc. et al. (D. Del.). Trial counsel for Endo Pharmaceuticals in Hatch-Waxman case involving Endo's OPANA ER® product. Following a bench trial, the court ruled in Endo's favor, finding the asserted patent not invalid.
  • Endo Pharmaceuticals Inc. et al. v. Teva Pharmaceuticals USA, Inc. et al. (S.D.N.Y.). Trial counsel for Endo Pharmaceuticals in Hatch-Waxman case filed against seven generic companies involving Endo's OPANA ER® product. Following a five-week bench trial, the court ruled in Endo's favor, finding its patents infringed and not invalid. Currently on appeal.
  • Activision Blizzard, Inc., Blizzard Entertainment, Inc. and Activision Publishing, Inc. in a multi-patent infringement dispute involving network communications for online gaming products.
  • ADP AdvancedMD, Inc. in a patent infringement dispute involving healthcare information technology relating to insurance claim processing.
  • An investment services company in a patent infringement dispute involving portfolio analysis.
  • A life sciences company in a patent infringement dispute involving DNA sequencing technology.
  • Wisconsin Alumni Research Foundation in a patent infringement dispute involving computer microarchitecture.
  • Novellus Systems, Inc. in a patent infringement dispute involving semiconductor processing equipment.
Includes matters handled at Dechert or prior to joining the firm.
Education
  • Yale University, B.S., Chemistry, 2002, magna cum laude
  • California Institute of Technology, M.S., Chemistry, 2004
  • University of California, Berkeley, School of Law, J.D., 2008, Order of the Coif
Admissions
  • Texas
  • California
  • Massachusetts
  • United States District Court for the Northern District of California
  • United States District Court for the District of Massachusetts
  • United States Court of Appeals for the Federal Circuit